Arbutus Biopharma Corp. | Mutual Funds
Mutual Funds that own Arbutus Biopharma Corp.
PRIMECAP Odyssey Aggressive Growth Fund
4,000,400
7.22%
0
0.32%
06/30/2018
iShares Russell 2000 ETF
738,834
1.33%
-396
0.01%
09/06/2018
iShares Nasdaq Biotechnology ETF
641,197
1.15%
-8,379
0.06%
09/06/2018
AXA Framlington Biotech Fund
535,644
0.97%
-234,717
0.69%
02/28/2018
iShares Russell 2000 Value ETF
245,309
0.44%
0
0.02%
09/06/2018
iShares Russell 2000 Growth ETF
117,459
0.21%
0
0.01%
09/06/2018
Dreyfus Select Managers Small Cap Growth Fund
111,731
0.2%
111,731
0.11%
07/31/2018
iShares Micro Cap ETF
94,285
0.17%
0
0.08%
09/06/2018
SEI Institutional Managed Trust - Small Cap Fund
79,000
0.14%
0
0.09%
08/31/2018
72,510
0.13%
0
0.25%
06/30/2018
| Address |
8900 Glenlyon Parkway
Burnaby British Columbia V5J 5J8
Canada
|
|
Employees
|
- |
| Website |
http://www.arbutusbio.com |
| Updated |
07/08/2019 |
| Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada. . |
